Medical Minute: Influence of Sleep Disturbances and Obesity on MS and Associated Symptoms

Review the clinical implications of sleep disorders and obesity for patients with MS and evidence-based recommendations for proper treatment.
Patricia K. Coyle, MD, FAAN, FANA
Patricia Melville, ANP-BC, MSCN
Format: Microsoft PowerPoint (.ppt)
File Size: 636 KB
Released: August 27, 2021


Provided by Consortium of Multiple Sclerosis Centers (CMSC), in collaboration with Clinical Care Options

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb

Related Content

Dr Greg Mattingly reviews the latest available clinical data for emerging diagnostic and therapy options for managing the mood disorders and TD, from Clinical Care Options (CCO)

Greg Mattingly, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: maximum of 1.0 hour of AAPA Category I CME credit Psychologists: 1.0 APA CE Credit Social Workers: 1.0 ACE CE Credit Released: November 22, 2021 Expired: November 21, 2022

Clinical Care Options (CCO) commentary by Sanjay Gupta, MD, on choosing the right VMAT2 inhibitor for TD

Sanjay Gupta, MD Released: November 19, 2021

Slides from a presentation that educates clinicians on Parkinson disease, including evaluation of new targets and formulations for wearing off.

Tatyana Simuni, MD Released: October 28, 2021

Slides from a presentation that educates clinicians on Huntington disease and the management of chorea

Victor W. Sung, MD Released: October 28, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.